May 06, 2025

Combo Therapy Shows Repigmentation Gains in Vitiligo

Ritlecitinib alone or with nbUVB therapy led to significant improvements in skin repigmentation among vitiligo patients, with more pronounced effects seen when both treatments were combined, according to a new phase 2b study.

Conexiant

May 01, 2025

Early-Onset Atopic Dermatitis Increases Risk of Pediatric Uveitis

Chronic uveitis can “lead to ocular damage, potentially resulting in cataracts, glaucoma, and amblyopia,” researchers noted.

Conexiant

April 29, 2025

New Oral Option Approved for GCA

The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.

Conexiant

April 28, 2025

Delgocitinib Cream Outperforms Alitretinoin in Trial

Topical delgocitinib improved eczema severity scores and caused fewer adverse events than oral alitretinoin in adults with severe chronic hand eczema, according to a phase 3 study.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 17, 2025

We Want Your Perspective!

Join our roster of respected specialists and share your clinical perspectives.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

Can Exclusive Breastfeeding Lower Atopic Dermatitis Risk?

An invited commentary in JAAD reviewed current evidence indicating that exclusive breastfeeding for the first 3 to 4 months decreases cumulative incidence of atopic dermatitis in the first 2 years of life.

Conexiant

April 11, 2025

Early Antibiotics Linked to Asthma, Eczema

Researchers found early-life antibiotic use was linked to increased risk of asthma and eczema, but not most other immune diseases, after adjusting for familial factors.

Conexiant